Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model ; volume:47 ; number:6 ; year:2018 ; pages:2233-2249
Cellular physiology and biochemistry ; 47, Heft 6 (2018), 2233-2249

Creator: Lee, Sungmin
Son, Beomseok
Jeon, Jaewan
Park, Gaeul
Kim, Hyunwoo
Kang, Hyunkoo
Youn, HyeSook
Jo, Sunmi
Song, Jie-Young
Youn, BuHyun

DOI: 10.1159/000491535

URN: urn:nbn:de:101:1-2018080200320474102187

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lee, Sungmin
Son, Beomseok
Jeon, Jaewan
Park, Gaeul
Kim, Hyunwoo
Kang, Hyunkoo
Youn, HyeSook
Jo, Sunmi
Song, Jie-Young
Youn, BuHyun

Other Objects (12)

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease

Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease

Betaine in ameliorating alcohol-induced hepatic steatosis

Melatonin: a potential intervention for hepatic steatosis

Role of SCAP/SREBP in Hepatic Steatosis

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease

Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease

Betaine in ameliorating alcohol-induced hepatic steatosis

Melatonin: a potential intervention for hepatic steatosis

Role of SCAP/SREBP in Hepatic Steatosis

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease

Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease

Betaine in ameliorating alcohol-induced hepatic steatosis

Melatonin: a potential intervention for hepatic steatosis

Role of SCAP/SREBP in Hepatic Steatosis

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease

Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease

Betaine in ameliorating alcohol-induced hepatic steatosis

Melatonin: a potential intervention for hepatic steatosis

Role of SCAP/SREBP in Hepatic Steatosis

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease

Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease

Betaine in ameliorating alcohol-induced hepatic steatosis

Melatonin: a potential intervention for hepatic steatosis

Role of SCAP/SREBP in Hepatic Steatosis

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease

Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease

Betaine in ameliorating alcohol-induced hepatic steatosis

Melatonin: a potential intervention for hepatic steatosis

Role of SCAP/SREBP in Hepatic Steatosis

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro

Related objects

Reset password